Upstream Biosciences Inc. Provides Corporate Update
11/15/2010 10:58:36 AM
More...
|
Upstream Biosciences Inc. Seeks Licensors or Acquirers for Drug Discovery Portfolio and Cancer Diagnostic Platform
8/10/2009 9:26:34 AM
More...
|
Upstream Biosciences Inc.'s Board of Directors Initiates Strategic Review
7/27/2009 8:22:40 AM
More...
|
Upstream Biosciences Inc.' Potential Tropical Disease Treatments Demonstrate Promising Signs of Efficacy at McGill University
10/7/2008 8:34:40 AM
More...
|
Upstream Biosciences Inc. Appoints Dr. Michael Hayden Killam Professor of Medical Genetics and the Canada Research Chair in Human Genetics to Its Scientific Advisory Board
10/1/2008 9:29:24 AM
More...
|
Upstream Biosciences Inc. Begins Animal Efficacy Testing for Trypanosomiasis Treatment
9/15/2008 9:31:11 AM
More...
|
Upstream Biosciences Inc. Begins Animal Efficacy Testing for Leishmaniasis Treatment
7/28/2008 9:37:32 AM
More...
|
Upstream Biosciences Inc. and McGill University to Collaborate on Testing of Potential Tropical Disease Treatments
7/9/2008 8:30:12 AM
More...
|
Upstream Biosciences Inc. Appoints University of North Carolina Chemoinformatics Expert to Scientific Advisory Board
6/25/2008 8:52:16 AM
More...
|
Upstream Biosciences Inc. Expects Increased Interest From Big Pharma as FDA's Proposed Priority Review Voucher Program Is Implemented
6/10/2008 10:24:09 AM
More...
|
|